Nerelimomab (BAYX1351) is a monoclonal antibody targeting tumor necrosis factor-alpha (TNF-??). This antibody is specifically designed for use in research studies investigating the pathophysiology and potential therapeutic interventions for sepsis. By inhibiting TNF-??, Nerelimomab serves as a valuable tool for elucidating the role of this cytokine in inflammatory responses and its impact on sepsis progression.
Nerelimomab (BAYX1351) is a monoclonal antibody targeting tumor necrosis factor-alpha (TNF-??). This antibody is specifically designed for use in research studies investigating the pathophysiology and potential therapeutic interventions for sepsis. By inhibiting TNF-??, Nerelimomab serves as a valuable tool for elucidating the role of this cytokine in inflammatory responses and its impact on sepsis progression.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
